meta_analysis
    2022
    High Quality

    Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis

    Siafis S, Ciray O, Wu H, Schneider-Thoma J, Bighelli I

    Published in Molecular Autism

    Methodology

    Network meta-analysis of 125 RCTs in children/adolescents (n=7450) and 18 RCTs in adults (n=1104) covering 41 drugs and 17 dietary supplements, with core symptoms as co-primary outcomes.

    Key Findings

    No dietary supplement showed robust, consistent efficacy for core autism symptoms; most supplement evidence was low certainty and driven by small trials.

    Conclusions

    There is still no treatment with convincing evidence for the core symptoms of ASD; supplement effects are uncertain.

    Limitations

    Indirect comparisons, sparse networks for individual supplements, heterogeneous rating scales.

    Related Health Concerns

    Study Details

    Year:2022
    Sample Size:8,554
    Quality Score:10/10

    Disclosures

    Funding

    Not specified

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.